Align Technology Inc
NASDAQ:ALGN
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
204.03
330.25
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Align Technology Inc
Align Technology Inc
Cash from Financing Activities
Align Technology Inc
Cash from Financing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Cash from Financing Activities
-$501.7m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-30%
|
|
|
Haemonetics Corp
NYSE:HAE
|
Cash from Financing Activities
$304.8m
|
CAGR 3-Years
3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Cash from Financing Activities
-$392m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-3%
|
|
|
ICU Medical Inc
NASDAQ:ICUI
|
Cash from Financing Activities
-$55.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Cash from Financing Activities
-$15.3m
|
CAGR 3-Years
28%
|
CAGR 5-Years
28%
|
CAGR 10-Years
-22%
|
|
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
Cash from Financing Activities
$410.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
Align Technology Inc
Glance View
Align Technology Inc. is a pioneering company in the field of orthodontics and dentistry, best known for its innovative Invisalign system, which offers a clear alternative to traditional metal braces. Founded in 1997, the company has revolutionized the way orthodontic treatment is delivered, leveraging advanced 3D imaging technology to create customized, comfortable, and discreet aligners for patients. Align's unique approach not only enhances patient experience but also empowers dental professionals with state-of-the-art tools to improve treatment efficiency. The company has experienced robust growth, expanding its global footprint and establishing a strong brand reputation among both consumers and practitioners. For investors, Align Technology represents an exciting opportunity in the booming dental health market, which has been driven by increasing consumer awareness of oral health and aesthetic preferences. With a solid track record of revenue growth and profitability, Align continues to innovate, expanding its product offerings beyond aligners to include digital scanning solutions and practice management software. Their investments in research and development, along with strategic partnerships in the orthodontic field, position Align Technology favorably for future growth. As the company navigates the evolving landscape of dental care, it remains committed to its mission of transforming smiles, making it an appealing choice for those looking to invest in a forward-thinking healthcare leader.
See Also
What is Align Technology Inc's Cash from Financing Activities?
Cash from Financing Activities
-501.7m
USD
Based on the financial report for Sep 30, 2024, Align Technology Inc's Cash from Financing Activities amounts to -501.7m USD.
What is Align Technology Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-30%
Over the last year, the Cash from Financing Activities growth was -12%. The average annual Cash from Financing Activities growth rates for Align Technology Inc have been -12% over the past three years , -3% over the past five years , and -30% over the past ten years .
You don't have any saved screeners yet
